The company was pleased to report the findings of a late-stage clinical trial of its advanced flu vaccine. Moderna (NASDAQ: ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

The head of the U.S. Department of Veterans Affairs (VA) says he’s “particularly proud” of the administration’s work to ...

Carrie Kitko, MD, explains that axatilimab maintains strong response rates in patients with chronic graft-versus-host disease (GVHD) regardless of previous treatment lines and emphasizes the need to ...

MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...

In February 2025, the NMPA approved a Phase III trial of InnoCare Pharma’s ICP-248 (Mesutoclax) with orelabrutinib as a first ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

After five years of civil confinement, a man who is accused of raping a woman in 1994 can still be held indefinitely, the ...

"BioAtla presents Phase I data of BA3182 for metastatic adenocarcinoma" was originally created and published by Clinical ...

Summit Therapeutics nears a $15B AstraZeneca deal for ivonescimab, targeting a $90B market. See more on the potential and ...

Moreover, SciatiEase Reviews frequently highlight inconsistent results: some customers report modest improvements in Sciatic ...